NCT05434065View on ClinicalTrials.gov

Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

Celecoxib 200mg

Using celecoxib (200 mg/day) for 21 days starting within 6 hours after onset of ICH

Trial Locations (1)

100

RECRUITING

Natinal Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER